Publications

June 2010 (Revised May 2017)
Teaching Note

Sydney IVF: Stem Cell Research

By: Robert Simons and Kathryn Rosenberg

Teaching Note for 109017. View Details

Keywords: Strategy And Execution; Management Control Systems; Levers Of Control; Strategy; Risk Management; Decisions; Cooperative Ownership; Product Development; Moral Sensibility; Governing Rules, Regulations, and Reforms; Expansion; Science-Based Business; Research; Management Practices and Processes; Business Subsidiaries; Biotechnology Industry; Sydney

January 2006
Case

Jack Strang at SequenceLabs

By: Mukti Khaire, John J. Gabarro and Lynda M. Applegate

How can entrepreneur manage his firm if things go wrong despite having a great idea, a solid team, and financial backing? Jack Strang founded a biotech firm with his friend Peter Evans, to develop molecular pathway-based "cures" for metabolic disorders. The idea was... View Details

Keywords: Corporate Entrepreneurship; Business or Company Management; Venture Capital; Factories, Labs, and Plants; Business Growth and Maturation; Failure; Biotechnology Industry

1999
Chapter

Biotechnology, Competitiveness and the Regulatory State

By: Arthur A. Daemmrich

Keywords: Technological Innovation; Innovation Strategy; Competitive Advantage; Governing Rules, Regulations, and Reforms; Government and Politics; Policy; Business and Government Relations; Biotechnology Industry

December 2001 (Revised June 2002)
Case

Monsanto: Technology Cooperation and Small Holder Farmer Projects

By: James E. Austin, Diana Barrett and Stephanie Oestreich

As the leading plant technology company in the global food system, how can Monsanto share this technology with small-sale producers and not-for-profit researchers and institutions? View Details

Keywords: Food; Globalized Markets and Industries; Corporate Social Responsibility and Impact; Nonprofit Organizations; Society; Technology; Biotechnology Industry

December 1994
Case

Alpha-Beta Technology, Inc. (B): Trials with Betafectin

This case follows the development of a firm's first product, the public presentation of research results, and the stock market reactions. In spite of successful research, the stock price falls dramatically. Asks why this happened, how concerned the CEO should be,... View Details

Keywords: Product Development; Biotechnology Industry

August 2007
Article

Financial Contracting in Biotech Strategic Alliances

Keywords: Finance; Contracts; Science; Strategy; Alliances; Biotechnology Industry

May 1992 (Revised February 1996)
Teaching Note

Nucleon, Inc., Teaching Note

By: Gary P. Pisano

Teaching Note for (9-692-041). View Details

Keywords: Biotechnology Industry

October 1994 (Revised November 1994)
Case

DNA Plant Technology Corporation (DNAP)

By: Ray A. Goldberg and Quintus Travis

Keywords: Biotechnology Industry

November 1985
Case

Genetics Institute Enters the Seed Business

By: Ray A. Goldberg and Michael Joseph Kennedy

Keywords: Competitive Strategy; Biotechnology Industry

November 1978 (Revised February 1990)
Case

Amicon Corp. (C)

Details the negotiations between Amicon and one potential licensee, Jackson. View Details

Keywords: Technology; Patents; Negotiation Process; Negotiation Participants; Health Care and Treatment; Biotechnology Industry

01 Jun 2000
News

The Right Connections

resources -- what we call social capital." Organizational behaviorists have known for years that third-party endorsements are critical to a young firm's success. Higgins and Gulati wanted to understand the origins and nature of these important relationships. They... View Details

Keywords: Judith A. Ross

01 Dec 2003
News

The Next Big Thing

research and commercialization of biotechnology and biomedicine, the life sciences’ core activities? And what steps must be taken to maintain preeminence? In a keynote presentation at a September “Massachusetts Life Sciences Summit,” HBS... View Details

Keywords: life sciences; Scientific Research and Development Services

15 Apr 2014
News

Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize

entrepreneur who has had a successful career in business, finance, yachting, and philanthropy. He is the former CEO of Serono SA (formerly known Ares-Serono), a family-controlled global pharmaceuticals and biotechnology leader whose roots... View Details

Keywords: i-Lab; Harvard Medical School; Scientific Research and Development Services

02 Aug 2004
Research & Ideas

Health Care Research and Prospects

is a lot other work at the school going on around these issues by many other faculty. For instance, Dave Scharfstein is doing great work on how capital market forces influence the development strategies of biotechnology companies. David... View Details

Keywords: by Wendy Guild Swearingen; Health

July 1993
Case

Genzyme Corporation: A Financing History

By: Timothy A. Luehrman and Andrew D. Regan

Genzyme Corp.'s financing history is unusual compared to most biotech companies. This case presents the sequence of financings employed by Genzyme, along with the product--market and corporate-development strategies adopted by Henri Termeer, Genzyme's CEO. As such, the... View Details

Keywords: History; Marketing Strategy; Financing and Loans; Business Strategy; Growth and Development Strategy; Biotechnology Industry

July 2023
Case

Moderna: Everything, Everywhere, All at Once

By: Satish Tadikonda, Shikhar Ghosh and William Marks

Coming out of the COVID-19 pandemic, Moderna was riding the successes of developing a vaccine in record time and helping stem the tide of the crisis. However, the company had grown at an incredible rate, more than doubled its number of employees, and had to put on hold... View Details

Keywords: Health Pandemics; Selection and Staffing; Growth Management; Management Succession; Retirement; Technological Innovation; Corporate Strategy; Biotechnology Industry

November 2016
Case

QuintilesIMS: Biosimilar Marketing in England

By: John A. Quelch and Emily C. Boudreau

QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical... View Details

Keywords: Health; Pharmaceutical Industry; Biotech; Marketing; Health Care and Treatment; Biotechnology Industry; England

2009
Case

Innovamedica: Innovation in an Emerging Market

By: Roberto Charvel, Fernando Fabre and T. Putimahtama

Innovamedica was a medical start up with several state of the art devices such as a silicon substitute heart and other inventions. However, the founding scientist was struggling in attracting talent and fundraising and that had an impact on growth. View Details

Keywords: Biotech; Entrepreneurial Finance; Entrepreneurship; Start-up; Emergent Countries; Business Startups; Talent and Talent Management; Design; Corporate Entrepreneurship; Private Equity; Health Testing and Trials; Innovation and Invention; Managerial Roles; Biotechnology Industry; Latin America; North and Central America

March 2012 (Revised October 2013)
Supplement

Gene Patents (B)

By: Richard Hamermesh and Phillip Andrews

The case updates events since the Court's ruling against Myriad Genetics on March 29, 2010 and should be used in conjunction with Gene Patents (A). On July 29, 2011, a US Appeals Court reversed the prior ruling against Myriad. On September 16, 2011, the first major... View Details

Keywords: Courts and Trials; Patents; Genetics; Judgments; Investment; Biotechnology Industry; United States